At least $31,021 in Medicaid payments were made in Garden Grove in 2024 for services billed under HCPCS codes specifically categorized as COVID-19, based on data provided by the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid, a public health insurance program supported jointly by federal and state governments and administered by the states, covers low-income people, children, seniors, and those with disabilities. It represents one of the largest elements of the nation’s health care system.
As Medicaid uses taxpayer funding, shifts in local billing data illustrate how public health care resources are distributed within a community.
For this review, COVID-19–related services are defined by HCPCS codes described or marked as “COVID-19” or “coronavirus” in billing records or reference files. Thus, totals reflect only those services specifically labeled as COVID-related and do not encompass all pandemic-related care that could be billed under broader or alternate codes.
For comparison, the highest COVID-19 Medicaid payment total in California for 2024 was in San Jose, with $5,601,479 in claims associated with virus-specific services.
In Garden Grove, five providers billed Medicaid for COVID-19–related services during 2024. COVID-19 vaccine administration was the most-billed code, totaling $15,790.
The average provider Medicaid payment for COVID-19–related services in Garden Grove reached $6,204, well below the $52,976 statewide average.
During the pandemic years, growth in Medicaid spending in Garden Grove was largely driven by COVID-19–specific services.
Across all non-COVID claim types, overall Medicaid payments increased by $7,445,411 between 2020 and 2024, equal to a 12.1% gain.
In the two years before the pandemic, Garden Grove’s average annual Medicaid payments were $62,418,196.
The Centers for Medicare & Medicaid Services reports that combined state and federal Medicaid spending reached about $871.7 billion in fiscal year 2023. That figure represents roughly 18% of overall national health expenditures and is an increase from $613.5 billion in 2019, before the pandemic.
This rise equates to growth of about 40% over just a few years, primarily due to greater Medicaid enrollment and higher service use during and after the pandemic period.
Recent federal budget acts under the Trump administration featured major proposals to decrease federal Medicaid allocations and restructure the program. The “One Big Beautiful Bill Act,” signed into law in 2025, is predicted to reduce federal Medicaid spending by over $1 trillion in the next 10 years, while implementing requirements such as work mandates and increased cost-sharing. These adjustments may reduce benefits and funding for certain Medicaid participants, potentially shifting more costs onto states even as tens of millions continue to rely on the program.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $31,021 | -74.3% | $68,832,042 |
| 2023 | $120,565 | -95.2% | $72,103,245 |
| 2022 | $2,525,661 | -25.4% | $67,582,722 |
| 2021 | $3,385,805 | 215.9% | $72,023,264 |
| 2020 | $1,071,857 | N/A | $62,427,467 |
| 2019 | $0 | N/A | $63,857,723 |
| 2018 | $0 | N/A | $60,978,669 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 90480 | COVID-19 Vaccine Administration | $15,790 | 874 |
| 87811 | Immunoassay | $11,356 | 1,313 |
| 87635 | COVID Specific | $3,875 | 105 |
Note: Data includes only HCPCS codes specifically for COVID-19 services; not all pandemic-related health spending is reflected in these totals.
Details for this report are sourced from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The complete source can be accessed here.
